Home > Journals > Gazzetta Medica Italiana Archivio per le Scienze Mediche > Past Issues > Gazzetta Medica Italiana Archivio per le Scienze Mediche 1999 June;158(3) > Gazzetta Medica Italiana Archivio per le Scienze Mediche 1999 June;158(3):87-9

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE

A Journal on Internal Medicine and Pharmacology


Indexed/Abstracted in: BIOSIS Previews, EMBASE, Scopus, Emerging Sources Citation Index

 

CLINICAL CASES  


Gazzetta Medica Italiana Archivio per le Scienze Mediche 1999 June;158(3):87-9

Copyright © 1999 EDIZIONI MINERVA MEDICA

language: Italian

Schistosomiasis, carcinoid tumor and acute appendicitis. A new trilogy

Maculotti L. 1, Pradella P. 2

1 Azienda Ospedaliera, Ospedale Niguarda Ca’ Granda - Milano, Divisione di Chirurgia Generale Andrea Ponti; 2 Azienda Ospedaliera, Ospedale Niguarda Ca’ Granda - Milano, Divisione di Chirurgia Generale d’Urgenza


PDF  


A new trilogy, formed by schistosomiasis, carcinoid tumor and acute appendicitis, in an Egyptian 22-year-old man, recently immigrated in Italy, is presented. If the association of schistosomiasis with acute appendicitis is rare (2.4% in Nigeria) and extremely rare the association of carcinoid tumor with acute appendicitis (0.3-0.75%), no checking of trilogy has been found in Medline and Biosis. So that this case may be the first one indexed in the literature. No diagnostic aid was given by the clinic, that brought to operating theatre the young Egyptian patient for a typical attack of acute appendicitis. Only pathological anatomy led to the diagnosis, pointing out schistosoma eggs in the lumen of the appendix, carcinoid tumor infiltrating muscular layer in the third distal of the organ and appendiceal phlegmon. Appendicectomy was considered a sufficient surgical therapy for the inflammation of the tissue in similar cases and for the distally localized tumor, and medical therapy with praziquantel was right for intestinal schistosomiasis. The 5-year-follow-up may be correct for low malignancy tumors with less than 3% of metastasis incidence rate.

top of page

Publication History

Cite this article as

Corresponding author e-mail